|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.41 - 0.44|
|52 Week Range||0.32 - 3.26|
|PE Ratio (TTM)||-0.58|
|Earnings Date||May 4, 2017 - May 8, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||3.00|
BEDMINSTER, NJ / ACCESSWIRE / August 17, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...
Investors in CorMedix (CRMD) need to pay close attention to the stock based on moves in the options market lately.
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time Recent Corporate and Clinical Highlights : Implemented several key FDA-agreed changes to the LOCK-IT-100 trial designed to enhance event capture ...